[PHARMA] YoY TTM Result on 30-Jun-2016 [#2]

Announcement Date
19-Aug-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- -1.73%
YoY- -30.36%
Quarter Report
View:
Show?
TTM Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 2,572,302 2,388,351 2,234,292 2,295,554 2,113,938 2,002,411 1,846,836 5.67%
PBT 72,267 75,814 61,919 97,079 126,467 109,249 79,270 -1.52%
Tax -23,482 -26,481 -21,162 -26,952 -26,277 -41,209 -29,878 -3.93%
NP 48,785 49,333 40,757 70,127 100,190 68,040 49,392 -0.20%
-
NP to SH 48,386 48,260 40,668 69,407 99,663 66,756 47,949 0.15%
-
Tax Rate 32.49% 34.93% 34.18% 27.76% 20.78% 37.72% 37.69% -
Total Cost 2,523,517 2,339,018 2,193,535 2,225,427 2,013,748 1,934,371 1,797,444 5.81%
-
Net Worth 518,564 519,642 542,147 524,177 528,477 502,293 480,568 1.27%
Dividend
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Div 40,348 51,929 38,883 64,750 88,011 44,519 41,172 -0.33%
Div Payout % 83.39% 107.60% 95.61% 93.29% 88.31% 66.69% 85.87% -
Equity
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Net Worth 518,564 519,642 542,147 524,177 528,477 502,293 480,568 1.27%
NOSH 261,229 259,821 259,400 258,981 259,057 258,914 258,370 0.18%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin 1.90% 2.07% 1.82% 3.05% 4.74% 3.40% 2.67% -
ROE 9.33% 9.29% 7.50% 13.24% 18.86% 13.29% 9.98% -
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
RPS 987.13 919.23 861.33 886.38 816.01 773.39 714.80 5.52%
EPS 18.57 18.57 15.68 26.80 38.47 25.78 18.56 0.00%
DPS 15.50 20.00 15.00 25.00 34.00 17.20 15.94 -0.46%
NAPS 1.99 2.00 2.09 2.024 2.04 1.94 1.86 1.13%
Adjusted Per Share Value based on latest NOSH - 258,981
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
RPS 178.48 165.72 155.03 159.28 146.68 138.94 128.14 5.67%
EPS 3.36 3.35 2.82 4.82 6.92 4.63 3.33 0.14%
DPS 2.80 3.60 2.70 4.49 6.11 3.09 2.86 -0.35%
NAPS 0.3598 0.3606 0.3762 0.3637 0.3667 0.3485 0.3334 1.27%
Price Multiplier on Financial Quarter End Date
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Date 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 -
Price 2.84 2.88 4.58 5.50 7.13 4.61 4.49 -
P/RPS 0.29 0.31 0.53 0.62 0.87 0.60 0.63 -12.12%
P/EPS 15.29 15.51 29.21 20.52 18.53 17.88 24.19 -7.35%
EY 6.54 6.45 3.42 4.87 5.40 5.59 4.13 7.95%
DY 5.46 6.94 3.28 4.55 4.77 3.73 3.55 7.43%
P/NAPS 1.43 1.44 2.19 2.72 3.50 2.38 2.41 -8.32%
Price Multiplier on Announcement Date
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Date 23/08/19 17/08/18 16/08/17 19/08/16 17/08/15 21/08/14 16/08/13 -
Price 2.66 3.11 4.19 5.62 5.65 4.62 4.66 -
P/RPS 0.27 0.34 0.49 0.63 0.69 0.60 0.65 -13.61%
P/EPS 14.33 16.74 26.73 20.97 14.69 17.92 25.11 -8.92%
EY 6.98 5.97 3.74 4.77 6.81 5.58 3.98 9.81%
DY 5.83 6.43 3.58 4.45 6.02 3.72 3.42 9.29%
P/NAPS 1.34 1.56 2.00 2.78 2.77 2.38 2.51 -9.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment